
Soritene0.1%
Beximco Pharmaceuticals Ltd.
Tazarotene is a topical retinoid indicated for the following uses, classified by strength of evidence: FDA-approved – Plaque psoriasis: Tazarotene is indicated for the topical treatment of…
Tazarotene is a topical retinoid indicated for the following uses, classified by strength of evidence:
Tazarotene is for topical (external skin) use only. It should be applied as a thin film once daily, in the evening, to clean, dry skin, unless a physician directs otherwise. Avoid application to the eyes, eyelids, lips, angles of the nose, mucous membranes, and normal (non-affected) surrounding skin. Wash hands after application.
| Indication | Recommended Use |
|---|---|
| Plaque psoriasis | Apply a thin film of Tazarotene cream or gel (0.05% or 0.1%) once daily in the evening to the psoriatic lesions, covering no more than the body surface area specified by the prescriber. Adjacent healthy skin should be protected. |
| Acne vulgaris | Apply a thin film of Tazarotene cream, gel, foam, or lotion (0.045% or 0.1%, per product) once daily in the evening to the entire affected area of the face and/or trunk, after the skin is clean and dry. |
| Photodamage (facial fine wrinkling, mottled hyper-/hypopigmentation, benign lentigines) | Apply a pea-sized amount of Tazarotene 0.1% cream once daily in the evening to the face only, as part of a comprehensive skin care and sun-protection programme, under physician supervision. |
Therapy is usually started at a lower strength/frequency and adjusted based on tolerability. If significant irritation occurs, application may be reduced to alternate evenings or a lower-strength formulation may be substituted, as advised by the prescriber. Do not apply more Tazarotene than directed, and do not apply to a larger area than prescribed. See Precautions and Warnings for guidance on sun exposure and skin irritation.
The most common adverse effects of Tazarotene are local skin reactions at the application site, which are often most pronounced during the first few weeks of treatment and tend to lessen with continued use:
Less common effects include: localized skin pain, contact dermatitis, skin discoloration (hyper- or hypopigmentation), a transient worsening of psoriasis, and rash. Photosensitivity reactions can occur (see Precautions and Warnings). Severe irritation or allergic contact dermatitis is uncommon but should prompt discontinuation of Tazarotene and medical review.
Tazarotene is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.